Figure 3 () TUNEL-positive myocytes nuclei (brown) demonstrated with the ApopTag kit

The transverse section is from the left ventricle in a case of SND (× 200 magnifications). The insert: Higher magnification (× 400) of the same section showing complete labelling of myocytes nuclei. () Myocytic necrosis visualized by the binding of antibody against the terminal complement complex (purple) to the sarcolemma. The longitudinal is from the left ventricle in a case of LLT group (× 200 magnification).Insert: Higher magnification (× 400) of the same section showing immunoreactivity of cardiac myocytes to the C9-mab. The endothelium of intramyocardial vessels also reacted with C9-ab and used as an internal control (arrow).<b>Copyright information:</b>Taken from "Pathogenic role of cardiac mast cell activation/degranulation, TNF-α, and cell death in acute drug-related fatalities"Vascular Health and Risk Management 2007;3(6):1053-1062.Published online Jan 2007PMCID:PMC2350147.© 2007 Perskvist et al, publisher and licensee Dove Medical Press Ltd.